Home › Research › Prevention and risk
Trial of the MIND Diet for Prevention of Cognitive Decline in Older Persons
Barnes LL, Dhana K, Liu X, Carey VJ, Ventrelle J, Johnson K, et al.. New England Journal of Medicine, 2023-07-18
Topic: Risk, prevention and care in population studies
Plain-language summary
Background Findings from observational studies suggest that dietary patterns may offer protective benefits against cognitive decline, but data from clinical trials are limited. The Mediterranean-DASH Intervention for Neurodegenerative Delay, known as the MIND diet, is a hybrid of the Mediterranean diet and the DASH (Dietary Approaches to Stop Hypertension) diet, with modifications to include foods that have been putatively associated with a decreased risk of dementia. Methods We performed a two-site, randomized, controlled trial involving older adults without cognitive impairment but with a family history of dementia, a body-mass index (the weight in kilograms divided by the square of the height in meters) greater than 25, and a suboptimal diet, as determined by means of a 14-item questionnaire, to test the cognitive effects of the MIND diet with mild caloric restriction as compared with a control diet with mild caloric restriction. Results A total of 1929 persons underwent screening, and 604 were enrolled; 301 were assigned to the MIND-diet group and 303 to the control-diet group. Conclusions Among cognitively unimpaired participants with a family history of dementia, changes in cognition and brain MRI outcomes from baseline to year 3 did not differ significantly between those who followed the MIND diet and those who followed the control diet with mild caloric restriction.
What this study adds
Evidence grade: Null result
The record lists 604 participants. In this randomized trial, people without cognitive impairment who followed the MIND diet showed no significant difference in cognition or brain MRI results after three years compared with those on a control diet. Reported effect size: Global cognition mean difference 0.035 standardised units (95% CI -0.022 to 0.092; P=0.23).
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Barnes, L. L., Dhana, K., Liu, X., Carey, V. J., Ventrelle, J., Johnson, K., et al. (2023). Trial of the MIND Diet for Prevention of Cognitive Decline in Older Persons. New England Journal of Medicine. https://doi.org/10.1056/NEJMoa2302368
Vancouver
Barnes LL, Dhana K, Liu X, Carey VJ, Ventrelle J, Johnson K, et al. Trial of the MIND Diet for Prevention of Cognitive Decline in Older Persons. New England Journal of Medicine. 2023. doi:10.1056/NEJMoa2302368. PMID: 37466280.
BibTeX
@article{barnes2023-37466280,
author = {Barnes, L. L. and Dhana, K. and Liu, X. and Carey, V. J. and Ventrelle, J. and Johnson, K. and others},
title = {{Trial of the MIND Diet for Prevention of Cognitive Decline in Older Persons}},
journal = {New England Journal of Medicine},
year = {2023},
doi = {10.1056/NEJMoa2302368},
pmid = {37466280},
url = {https://doi.org/10.1056/NEJMoa2302368}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Background Findings from observational studies suggest that dietary patterns may offer protective benefits against cognitive decline, but data from clinical trials are limited.
- The Mediterranean-DASH Intervention for Neurodegenerative Delay, known as the MIND diet, is a hybrid of the Mediterranean diet and the DASH (Dietary Approaches to Stop Hypertension) diet, with modifications to include foods that have been putatively associated with a decreased risk of dementia.
- Methods We performed a two-site, randomized, controlled trial involving older adults without cognitive impairment but with a family history of dementia, a body-mass index (the weight in kilograms divided by the square of the height in meters) greater than 25, and a suboptimal diet, as determined by means of a 14-item questionnaire, to test the cognitive effects of the MIND diet with mild caloric restriction as compared with a control diet with mild caloric restriction.
- Results A total of 1929 persons underwent screening, and 604 were enrolled; 301 were assigned to the MIND-diet group and 303 to the control-diet group.
- Conclusions Among cognitively unimpaired participants with a family history of dementia, changes in cognition and brain MRI outcomes from baseline to year 3 did not differ significantly between those who followed the MIND diet and those who followed the control diet with mild caloric restriction.
Why it matters
In this randomized trial, people without cognitive impairment who followed the MIND diet showed no significant difference in cognition or brain MRI results after three years compared with those on a control diet. It does not support the MIND diet as a way to prevent cognitive decline.
New to this subject? Start with our plain-English guide: Prevention →
Study details
- Study designRCT
- Participants604
- Effect sizeGlobal cognition mean difference 0.035 standardised units (95% CI -0.022 to 0.092; P=0.23)
- Evidence strengthNull-result
Limitations
Both arms received dietary counselling and weight-loss support, so the comparison is MIND versus a healthy control diet rather than versus usual eating; cognitively unimpaired participants over 3 years may be too short a window for dementia outcomes.
How this study scored 87/100
Published in a top-tier journal, and it is a randomized controlled trial. We have no data on free to read, so that was left out: it earned 85 of the 98 points we could judge it on, which is 87 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 10 / 10 | Tier 1 — top-tier general journal (New England Journal of Medicine) |
| Journal's citation record | 4 / 4 | New England Journal of Medicine: journal h-index 1,505 (OpenAlex, 2026-10-29) |
| Study design | 11 / 12 | A randomized controlled trial |
| Strength of evidence | 3 / 5 | Rated “null-result” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 3 / 5 | 2023 — within 6 year(s) of the newest study here |
| Sample size | 2 / 4 | 604 participants |
| Effect reported | 3 / 3 | Effect reported with a statistic (interval, p-value, ratio or similar) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 1 / 2 | Randomized (as stated in the record) |
| Times cited | 6 / 7 | Cited 357 times (OpenAlex, 2026-10-10) |
| Citations per year | 5 / 5 | 71.4 citations a year over 5 year(s) since 2023 |
| Impact for its field and year | 6 / 6 | Cited 83.3× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 3 / 6 | Cited by 22 other studies in this library |
| Still being cited | 4 / 4 | Cited 339 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 4 / 4 | Last-listed author Frank M. Sacks: h-index 126 (OpenAlex, whole career) |
| Institution's track record | 3 / 3 | Harvard University: institution h-index 3,235 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 5 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 37466280) |
| Free to read | — / 2 | Access not recorded — left out of this score |
| Points | 85 / 98 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 85 of the 98 points we could judge it on is 87 out of 100. |
| Total | 87 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — PubMed Central lists this copy as free to read: the link above (checked 10 Oct 2026).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
22 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.